The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
Open accessAbstract
Burkholderia cenocepacia is an opportunistic pathogen particularly dangerous for cystic fibrosis (CF) patients. It can cause a severe decline in CF lung function possibly developing into a life-threatening systemic infection known as cepacia syndrome. Antibiotic resistance and presence of numerous virulence determinants in the genome make B. cenocepacia extremely difficult to treat. Better understanding of its resistance profiles and mechanisms is crucial to improve management of these infections. Here we present the clinical distribution of B. cenocepacia described in the last six years and methods for identification and classification of epidemic strains. We also detail new antibiotics, clinical trials and alternative approaches reported in the literature in the last five years to tackle B. cenocepacia resistance issue. All together these findings point out the urgent need of new and alternative therapies to improve CF patients’ life expectancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Biological effects of essential oils—A review
Bakkali, F., Averbeck, S., Averbeck, D., & Idaomar, M. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.09.106 · Cited by 7,929
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Impact of Burkholderia Infection on Lung Transplantation in Cystic Fibrosis
Murray, S., Charbeneau, J., Marshall, B. C., & LiPuma, J. J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1834oc · Cited by 177 · cited 1×
“Several single-center or multicenter studies have suggested that poor outcomes might be a consequence of the infecting Bcc species (Murray et al., 2008).”
BackgroundAlexander, B. D., Petzold, E. W., Reller, L. B., Palmer, S. M., Davis, R. D., Woods, C. W., & LiPuma, J. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02186.x · Cited by 177
Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., Riccardi, G., Boon, N., Nelis, H. J., Mahenthiralingam, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058943 · Cited by 135 · cited 1×
“Van Acker et al. (2013) demonstrated that B. cenocepacia biofilms contain tolerant persister cells after tobramycin treatment.”
Self-citation
Cited by
Successful lung re-transplant in a patient with cepacia syndrome due to Burkholderia ambifaria
Goodlet, K. J., Nailor, M. D., Omar, A., Huang, J. L., LiPuma, J. J., Walia, R., & Tokman, S. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.08.011 · Cited by 12
Badten, A. J., Oaxaca-Torres, S., Basu, R. S., Gagnon, M. G., & Torres, A. G. (2025) · npj Vaccines · doi:10.1038/s41541-025-01246-2 · Cited by 4
Metadata
- Authors
- Scoffone, V. C., Chiarelli, L. R., Trespidi, G., Mentasti, M., Riccardi, G., & Buroni, S.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-08-22
- Volume
- 8
- Pages
- 1592-1592
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2750330993
- Cited by
- 183
- References
- 6
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches. https://app.cochat.ai/papers/10.3389/fmicb.2017.01592
- The paper
- Scoffone, V. C., Chiarelli, L. R., Trespidi, G., Mentasti, M., Riccardi, G., & Buroni, S. (2017). Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2017.01592
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.